Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019
Recruiting now · Phase 1
Conditions studied: Healthy Male Volunteers
In brief
The main purpose of this study is to determine the mass balance recovery and the metabolite profile of a single dose of carbon-14 (\[14C\]) GRT6019
Key facts
- Study ID
- NCT07479745
- Run by
- Grünenthal GmbH
- People needed
- 10
- Starts
- 2026-03-25
- Expected to finish
- 2026-06-06
- Last updated by the study team
- 2026-04-09
Who can join
Age: 30 and older, up to 65. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Healthy volunteers
- Aged 30 to 65 years inclusive at the time of signing informed consent
You may not qualify if…
- Serious adverse reaction or serious hypersensitivity to any drug or formulation excipients
- Presence or history of clinically significant allergy requiring treatment, as judged by the investigator. Hay fever is allowed unless it is active
- Presence or history of diseases or conditions known to interfere with the absorption, distribution, metabolism or excretion of drugs
- History of clinically significant cardiovascular, renal, hepatic, respiratory, particularly gastrointestinal (GI) disease, especially peptic ulceration, clinically significant GI bleeding, ulcerative colitis, Crohn's disease or irritable bowel syndrome, neurological or psychiatric disorder, or clinically significant dermatological disorder
- History of GI surgery (with the exception of appendectomy or hernia repair unless it was performed within the previous 12 months)
Where it is running
- Quotient Sciences — Nottingham, United Kingdom (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.